The global hematology analyzers and reagents market is projected to reach USD 10.6 billion by 2025 from USD 7.6 billion in 2020, at a CAGR of 6.9%.
Technological advancements in hematology analyzers and reagents, the integration of flow cytometry techniques with hematology analyzers, and the increasing incidence of blood disorders are the factors expected to drive the market during the study period. However, the high cost of hematology analyzers, product recalls, and slow adoption of advanced hematology instruments in emerging countries are factors restraining the growth of this market to a certain extent.
High-end hematology analyzers to be the fastest-growing segment during the forecast period.
By price range, the hematology instruments market is segmented into high-end, mid-range, and low-end hematology analyzers. The lower cost of these analyzers, in comparison with high-end analyzers, is a key factor driving the adoption of these instruments. Moreover, the smaller development, validation, and launch period for mid-range hematology analyzers (approximately two years) also contribute to overall market growth. As a result, several leading players are focused on the development of innovative technologies for mid-range hematology analyzers in the market
The Asia Pacific is expected to grow at the highest CAGR during the forecast period.
The Asia Pacific is expected to register the highest growth rate during the forecast period due to the increasing geriatric population and the resultant growth in the incidence of thalassemia, sickle-cell anemia, and leukemia. Moreover, the improved healthcare infrastructure in countries like Japan, China, and Australia; rising number of general surgeries and organ transplantations; and the growing number of ongoing research activities are other factors also contributing to the high growth of this segment.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights 4.1 Hematology Analyzers and Reagents Market Overview 4.2 Hematology Analyzers and Reagents Market, by Product & Service 4.3 Hematology Analyzers and Reagents Market, by End User 4.4 Geographic Snapshot of the Hematology Analyzers and Reagents Market
5 Hematology Analyzers and Reagents Market, by Product & Service 5.1 Introduction 5.2 Hematology Products & Services 5.2.1 Reagents & Consumables 126.96.36.199 Hematology Reagents 188.8.131.52.1 Growing Preference for Reagent Rental Business Models to Boost the Adoption of Hematology Reagents 184.108.40.206 Consumables 220.127.116.11.1 Consumables Are Reusable, Inexpensive, and Required in Limited Quantities; Supporting Their Adoption 18.104.22.168 Controls & Calibrators 22.214.171.124.1 Controls & Calibrators Offer the Highest Quality of Lab Results, Have Long-Term Stability, and Are Convenient to Use 126.96.36.199 Slide Stainers/Makers 188.8.131.52.1 Automated Slide Stainers/Makers Help Laboratories Provide Cost-Efficient, Reliable, and Uniform Staining Results 5.2.2 Instruments 184.108.40.206 5-Part and 6-Part Fully Automated Hematology Analyzers 220.127.116.11.1 Growing Preference for 5-Part and 6-Part Hematology Analyzers Due to Their Advantages to Drive Market Growth 18.104.22.168 3-Part Fully Automated Hematology Analyzers 22.214.171.124.1 3-Part Analyzers Offer Reduced Maintenance Costs, Making Them Ideal Cost-Effective Solutions for Developing Countries 126.96.36.199 Point-Of-Care Testing Hematology Analyzers 188.8.131.52.1 Rising Inclination Towards Home Testing of Blood Levels Will Lead to Market Growth 184.108.40.206 Semi-Automated Hematology Analyzers 220.127.116.11.1 Need for Manual Interruption Will Limit the Adoption of These Products 5.2.3 Services 18.104.22.168 High Adoption of Hematology Diagnostic Techniques Will Aid Market Growth 5.3 Hemostasis Products & Services 5.3.1 Reagents & Consumables 22.214.171.124 Rising Prevalence of Coagulation Disorders to Support Growth 5.3.2 Instruments 126.96.36.199 Hemostasis Instruments Offer Outstanding Productivity While Reducing Complexities and Increasing Output 5.3.3 Services 188.8.131.52 Advancements in Hemostasis Diagnostic Techniques Will Accelerate Market Growth 5.4 Immunohematology Products & Services 5.4.1 Reagents & Consumables 184.108.40.206 Development of Novel Immunohematology Reagents is Supporting Market Growth 5.4.2 Instruments 220.127.116.11 Growing Automation in Immunohematology Labs to Boost Market Growth 5.4.3 Services 18.104.22.168 Services Enable Customer-Focused Care - A Key Factor Driving Market Growth
6 Hematology Analyzers Market, by Price Range 6.1 Introduction 6.2 Low-End Hematology Analyzers 6.2.1 Lower Throughput Rates and Reduced Accuracy Will Hamper the Market Growth in This Segment 6.3 High-End Hematology Analyzers 6.3.1 High-End Analyzers Offer Advantages Such As Reliability, High Accuracy, Flexibility, and Ease of Use 6.4 Mid-Range Hematology Analyzers 6.4.1 Lower Cost of Mid-Range Hematology Analyzers in Comparison with High-End Analyzers - A Key Growth Driver
7 Hematology Analyzers and Reagents Market, by Application 7.1 Introduction 7.2 Hemorrhagic Conditions 7.2.1 Increase in Hemorrhagic Cases to Support the Adoption of Hematology Instruments 7.3 Infection-Related Conditions 7.3.1 Growing Burden of Infectious Diseases to Support the Adoption of Hematology Instruments 7.4 Immune System-Related Conditions 7.4.1 Rising Use in Point-Of-Care Applications is Likely to Aid the Adoption of Hematology Analyzers & Reagents 7.5 Blood Cancer 7.5.1 Hematology Analyzers Are Key Instruments Used for the Determination of Hematological Malignancies 7.6 Anemia 7.6.1 Growing Incidence of Anemia to Support the Adoption of Hematology Instruments 7.7 Other Applications
8 Hematology Analyzers and Reagents Market, by Usage Type 8.1 Introduction 8.2 Standalone Analyzers 8.2.1 Increased Use of Standalone Analyzers in Hospitals and Reference Labs to Drive Market Growth 8.3 Point-Of-Care Analyzers 8.3.1 Small Sample Requirement Leading to Increased Preference for Poc Analyzers Among End Users
9 Hematology Analyzers and Reagents Market, by End User 9.1 Introduction 9.2 Commercial Service Providers 9.2.1 Growing Outsourcing Will Increase the Market Growth in This Segment 9.3 Hospital Laboratories 9.3.1 High Prevalence of Blood-Related Disorders Will Result in High Market Growth 9.4 Government Reference Laboratories 9.4.1 Affordability and Provision of Free Services Are Likely to Propel the Growth of This End-User Segment 9.5 Research & Academic Institutes 9.5.1 Increasing Number of Drug Discovery and Research Activities to Support Market Growth
10 Hematology Analyzers and Reagents Market, by Region 10.1 Introduction 10.2 North America 10.2.1 US 10.2.1.1 Favorable Research Scenario Will Drive Market Growth in the Us 10.2.2 Canada 10.2.2.1 Rising Demand for Blood and Blood Components to Support Market Growth 10.3 Europe 10.3.1 Germany 10.3.1.1 Increasing Number of Anemic Patients is a Major Factor Driving the Growth of the Hematology Analyzers and Reagents Market in Germany 10.3.2 UK 10.3.2.1 Government Support to Develop Innovative Diagnostic Technologies Contributing to Market Growth 10.3.3 France 10.3.3.1 Presence of Proper Protocols and Guidelines in Diagnostics to Propel Market Growth in the Coming Years 10.3.4 Italy 10.3.4.1 Increasing Preference for Hematology Testing During Transplantation Will Result in Market Growth 10.3.5 Spain 10.3.5.1 Consolidation of Laboratories in Spain Will Drive Market Growth 10.3.6 Rest of Europe 10.4 Asia Pacific 10.4.1 China 10.4.1.1 Government Initiatives and Improving Healthcare Infrastructure To Aid Growth 124 10.4.2 Japan 10.4.2.1 Rising Prevalence of Flu in Japan in Recent Years is Contributing to Market Growth 10.4.3 India 10.4.3.1 High Burden of Chronic Diseases to Support Market Growth 10.4.4 Australia 10.4.4.1 Rising Prevalence of Celiac Disease to Support the Use of Hematology Analyzers and Reagents 10.4.5 South Korea 10.4.5.1 Rising Healthcare Spending Will Support Market Growth 10.4.6 Rest of Asia Pacific 10.5 Latin America 10.5.1 Brazil 10.5.1.1 Investments by Leading Hematology Analyzer and Reagent Manufacturers in the Country to Drive Market Growth 10.5.2 Mexico 10.5.2.1 Rising Prevalence of Diabetes and Cancer to Support Market Growth in Mexico 10.5.3 Rest of Latam 10.6 Middle East & Africa 10.6.1 MEA Will Hold a Smaller Share and Grow at a Lower Rate Than the Major Regional Markets